Project Number 5R01AG037481-04 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for LXR AND HUMAN APOE ISOFORM EFFECTS ON AD PHENOTYPE: IN VITRO AND IN VIVO MODELS Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 4. ApoE and Lipid Neurobiology g. Nuclear Receptors Researcher and Organization Principal Investigator KOLDAMOVA, RADOSVETA P Principal Investigator First Name RADOSVETA P Principal Investigator Last Name KOLDAMOVA Awardee Organization UNIVERSITY OF PITTSBURGH Awardee State Pennsylvania Contact PI Country United States Project Detail Funding Opportunity Announcement PA-09-217: The Role of Apolipoprotein E, Lipoprotein Receptors and CNS Lipid Homeostasis in Brain Aging and Alzheimer's Disease (R01) FY Overall Cost $366,252 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Related Resources Repository [AlzPED] Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"
